Not available
Quote | Pluristem Therapeutics Inc. (NASDAQ:PSTI)
Last: | $1.05 |
---|---|
Change Percent: | -1.58% |
Open: | $1.085 |
Close: | $1.05 |
High: | $1.085 |
Low: | $1.04 |
Volume: | 76,073 |
Last Trade Date Time: | 07/19/2022 04:39:04 am |
News | Pluristem Therapeutics Inc. (NASDAQ:PSTI)
HAIFA, Israel, July 25, 2022 (GLOBE NEWSWIRE) -- Pluri Inc. (Nasdaq: PLUR) (TASE: PLUR) (“Pluri” or the “Company”) (formerly known as Pluristem Therapeutics, Inc.), a leading biotechnology company, today issued an update to its shareholders from its Chief Executi...
Pluristem Therapeutics ( NASDAQ: PSTI ) said it changed its name to Pluri Inc. to reflect a strategy of using its 3D cell expansion technology to develop cell-based products for several fields beyond medicine. The company also changed its ticker symbol to PLUR from PST...
Message Board Posts | Pluristem Therapeutics Inc. (NASDAQ:PSTI)
Subject | By | Source | When |
---|---|---|---|
Everything Passed At The Shareholders Meeting !!! | FDApproved | investorshub | 04/27/2023 8:15:33 PM |
Mesenchymal Stem/stromal Cells (MSCs) or exosomes for disease | FDApproved | investorshub | 04/27/2023 4:23:18 PM |
Hopefully they set up shop in Haifa just | Scott999 | investorshub | 04/27/2023 3:24:02 PM |
I Like It !!! | FDApproved | investorshub | 04/27/2023 2:36:08 PM |
It Looks Like AstraZenca Has Taken A Keen | FDApproved | investorshub | 04/27/2023 1:50:50 PM |
News, Short Squeeze, Breakout and More Instantly...
Pluristem Therapeutics Inc. Company Name:
PSTI Stock Symbol:
NASDAQ Market:
Pluristem Therapeutics Inc. Website:
HAIFA, Israel, July 25, 2022 (GLOBE NEWSWIRE) -- Pluri Inc. (Nasdaq: PLUR) (TASE: PLUR) (“Pluri” or the “Company”) (formerly known as Pluristem Therapeutics, Inc.), a leading biotechnology company, today issued an update to its shareholders from its Chief Executi...
As of July 26 , 2022 , Pluri ’s stock will trade under the symbol PLUR The new name reflects the Company ’s strategy to leverage its innovative 3D cell-based technology to a range of fields, developing cel...
The Company will host an analyst and investor call to discuss the phase III muscle regeneration following hip fracture surgery topline results on July 14 at 9:00 a.m. ET; for registration: https://pluristem.zoom.us/webinar/register/WN_kp_CwQQtR-aFtjAXrdiJpA HAIFA, Israel, Ju...